Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Morphosys AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

22 Aug 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for MorphoSys AG

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

14 Aug 2015 Wright Reports 56 $75.00

Can a Battered MorphoSys AG Make a Comeback?

07 Aug 2015 Sadif Analytics Prime 12 $25.00

Phase 3-Partner Programme sind 2015 der Bewertungshebel – in Q2 wächst Pipeline erneut

Klassische Bewertungsmethoden (EV/EBIT, KGV etc.) greifen u.E. für ein Pharma- bzw. Biotech-Entwicklungs-Unternehmen zu kurz....

05 Aug 2015 EQUI.TS 4 $10.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) develops monoclonal antibodies for ther...

04 Aug 2015 GlobalData 43 $125.00

MORG.DE - Event Transcript of Morphosys AG conference call, Jul. 27, 2015 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, Jul. 27, 2015 / 8:00AM ET Boston, Jul 27, 2015 (Thomson StreetEvent...

27 Jul 2015 Thomson Reuters StreetEvents 11 $75.00

MorphoSys AG: Downgraded to Above Average

23 Jun 2015 Sadif Analytics Prime 3 $10.00

MORPHOSYS - A FIRST GLIMPSE OF MOR202’S POTENTIAL

Preliminary data from the Phase I/II study in multiple myeloma (MM) with MOR202 were promising and support our view that Celg...

04 Jun 2015 Edison Investment Research 8 $10.00

MORG.DE - Event Transcript of Morphosys AG conference call, Jun. 03, 2015 / 10:30AM ET

Edited Event Transcript of MORG.DE conference call, Jun. 03, 2015 / 10:30AM ET New York City, Jun 30, 2015 (Thomson Str...

03 Jun 2015 Thomson Reuters StreetEvents 7 $75.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) is a biotechnology company. The company...

19 May 2015 GlobalData 44 $125.00